Second, the rapid proteolytic degradation of the radiotracer after intravenous administration reduces the amount of intact conjugate reaching the tumor, thus impairing the uptake of radiolabeled minigastrins in CCK2R-positive tissues, such as a tumor or the stomach [14,15]. This evidence concerns the gene CCKBR and neoplasm.